187 filings
Page 4 of 10
8-K
wsn1qwo9yk2k tsz
21 May 20
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
1ep xwiy6p4yq
11 May 20
Marker Therapeutics Reports First Quarter 2020 Operating and Financial Results
4:17pm
8-K
q6rxx1gu1bo5
29 Apr 20
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia
4:17pm
8-K
bha0y5iw5n0so7d
12 Mar 20
Marker Therapeutics Reports Full Year 2019 Operating and Financial Results
4:38pm
8-K
dxd kvmxyygp6dk9
2 Mar 20
Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million
9:03am
8-K
m0ctwkrzv7dd27h
11 Feb 20
Marker Therapeutics Announces Update to its Clinical Program in AML
7:00am
8-K
fpswg sfg
12 Nov 19
Marker Therapeutics Reports Third Quarter 2019 Operating and Financial Results
4:16pm
8-K
q60kzpq 3g4tow
24 Sep 19
Regulation FD Disclosure
4:06pm
8-K
mf9xbr xcphfebml5nbd
15 Aug 19
Regulation FD Disclosure
4:17pm
8-K
ucupv4g
9 Aug 19
Marker Therapeutics Reports Second Quarter 2019 Operating and Financial Results
6:03am
8-K
ftza3im
6 Aug 19
Marker Therapeutics Appoints Steve Elms to its Board of Directors
4:48pm
8-K
yvfrydul
22 Jul 19
Regulation FD Disclosure
8:35am
8-K
47ejkk4r
19 Jul 19
Regulation FD Disclosure
9:14am
8-K
8znwn6ptqzdzp muvx
20 Jun 19
Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma
7:05am
8-K
7ag5c7
10 May 19
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
542ocd0q
9 May 19
Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results
5:07pm
8-K
aesxspdy kqsz9
17 Apr 19
Other Events
7:00am
8-K
nhqng
28 Mar 19
Marker Therapeutics Provides Business and Clinical Update
5:09pm
8-K
owyk9gg 4qj
25 Feb 19
Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
8:51am
8-K
09ypatttph 8acv
15 Feb 19
Marker Therapeutics Announces Change in Corporate Headquarters and Access to New Laboratory Facility
4:55pm